Shifting Gears in Cardio–Renal–Metabolic Care: Harnessing Evidenced-Based Therapies to Optimize Patient Outcomes

• Start Your Engines: Welcome, Opening Remarks, and Baseline Assessment: 3 min
• In the Driver’s Seat: Cardiology at the Helm of Optimizing GDMT in CRM: 20 min
• Shifting Into Gear: Optimizing GDMT in CRM With SGLT2 Inhibitors: 25 min
• Navigating the Curves: Counseling and Managing Side Effects for SGLT2 Inhibitors: 25 min
• Checkered Flag: Post Assessment and Evaluation: 2 min
• Victory Lap: Summarize Key Points and Question and Answer Session: 15 min

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners who care for patients with HF and/or CKD (with or without diabetes).

Target Audience
This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with HF and/or CKD (with or without diabetes).

Learning Objectives
Upon completion of this activity, participants should be able to:

• Identify persistent gaps in the care of patients with cardio-renal-metabolic disease and the clinical impact of delayed intervention

• Evaluate emerging evidence on the broad benefits of SGLT2 inhibitors in CRM care to inform earlier initiation and sustained use in appropriate patients

• Formulate strategies for effective patient counseling around integration of SGLT2 inhibitors into personalized care plans for patients with CRM conditions